Emily J Grade MD
Breast Cancer, Gynecologic Cancer, Skin Cancer
Banner MD Anderson Cancer Center
Join to View Full Profile
2940 E Banner Gateway DrSte 450Gilbert, AZ 85234
Phone+1 480-256-3676
Fax+1 480-256-3608
Dr. Grade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Emily Grade, MD, is a radiation oncologist based in Gilbert, AZ, with subspecialties in breast, gynecologic, and skin cancer. She completed her medical education and residency at the Medical College of Wisconsin and has been serving as an adjunct assistant professor at the UT MD Anderson Cancer Center since 2014. Dr. Grade has contributed to clinical research, with several publications cited by peers, and is actively involved in clinical trials, including those focused on breast and gynecologic cancers. Her work has earned her recognition with CMS Meaningful Use Stage 1 Certification across multiple platforms.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1987 - 1991- Medical College of WisconsinClass of 1987
Certifications & Licensure
CO State Medical License 2021 - 2027
AZ State Medical License 1991 - 2026
WI State Medical License 1988 - 1995
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2014, 2016
Clinical Trials
- Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue Start of enrollment: 2005 Apr 01
- Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Start of enrollment: 2012 Nov 01
- Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer Start of enrollment: 2017 Feb 23
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 44 citationsThree-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical TrialSimona F. Shaitelman, Xiudong Lei, Alastair M. Thompson, Pamela J. Schlembach, Elizabeth S. Bloom
Journal of Clinical Oncology. 2018-10-31 - 8 citationsPalliation or Prolongation? The Impact of a Peer-Review Intervention on Shortening Radiotherapy Schedules for Bone MetastasesGary V. Walker, Shervin M. Shirvani, Yerko Borghero, Matthew D. Callister, Daniel D. Chamberlain
Journal of Oncology Practice. 2018-07-30 - 13 citationsFive-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irr...Julius K. Weng, Xiudong Lei, Pamela J. Schlembach, Elizabeth S. Bloom, Simona F. Shaitelman
International Journal of Radiation Oncology, Biology, Physics. 2016-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
